000 01663 a2200457 4500
005 20250518051839.0
264 0 _c20201021
008 202010s 0 0 eng d
022 _a1664-3224
024 7 _a10.3389/fimmu.2019.01520
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAuderset, Floriane
245 0 0 _aReactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation.
_h[electronic resource]
260 _bFrontiers in immunology
_c2019
300 _a1520 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdjuvants, Immunologic
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aAntibodies, Bacterial
_ximmunology
650 0 4 _aBordetella pertussis
_ximmunology
650 0 4 _aFemale
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aPertussis Vaccine
_xgenetics
650 0 4 _aToll-Like Receptor 4
_xagonists
650 0 4 _aToll-Like Receptor 9
_xagonists
650 0 4 _aWhooping Cough
_ximmunology
700 1 _aBallester, Marie
700 1 _aMastelic-Gavillet, Beatris
700 1 _aFontannaz, Paola
700 1 _aChabaud-Riou, Martine
700 1 _aReveneau, Nathalie
700 1 _aGarinot, Marie
700 1 _aMistretta, Noƫlle
700 1 _aLiu, Yuanqing
700 1 _aLambert, Paul-Henri
700 1 _aOchs, Martina
700 1 _aSiegrist, Claire-Anne
773 0 _tFrontiers in immunology
_gvol. 10
_gp. 1520
856 4 0 _uhttps://doi.org/10.3389/fimmu.2019.01520
_zAvailable from publisher's website
999 _c29928588
_d29928588